Jurjen Versluis
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
Jurjen Versluis
Aug 4, 2024, 07:01 |
Insight
Rama Al Hamed: Allogeneic SCT in de novo core-binding factor AML in first complete remission
Rama Al Hamed, Hematology/Oncology Fellow at Herbert Irving Comprehensive Cancer Centre, shared on X: "Allogeneic…
Aug 25, 2023, 21:14 |
Insight
Jurjen Versluis: Allogeneic HCT should be considered as a curative treatment for all patients with high-risk MDS.
Jurjen Versluis, Internist hematologist and Researcher at Erasmus MC, shared the following insights on Twitter:…
All:
2
Posts:
1 - 100
A Manifesto to Improve Cancer Care in Conflict-Affected Areas: The Lancet
Why does Lionel Messi donate so much to charity?
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
Facebook
RSS Feed
Twitter
Linkedin
Youtube